Scrip: 世界の医療用医薬品＆製薬産業に関するニュース

Pfizer CEO Bourla Wants Profit From COVID-19 Vaccine

Several countries already are calling about orders, as the company prepares to begin a Phase III trial of its mRNA coronavirus vaccine candidate.

Topic Coronavirus Vaccines

Scrip: 世界の医療用医薬品＆製薬産業に関するニュース

Gilead Sets Remdesivir Price Commits Nearly All Near-Term Supplies To US

A five-day course will cost $2,340 for governments in developed countries and $3,120 for commercial payers. The US will get 100% of remdesivir manufactured by Gilead in July. 

Topic Coronavirus

Scrip: 世界の医療用医薬品＆製薬産業に関するニュース

Seizing The Day: How Coronavirus Breaks Then Makes Vaccine Makers In China

Amid fears of a second wave of coronavirus infections and the increasing dominance of state-owned enterprises, private vaccine makers in China are struggling to make the best of the outbreak, BravoVax CEO Ke Wu tells Scrip in an exclusive interview.

Topic Coronavirus Vaccines Clinical Trials

Scrip: 世界の医療用医薬品＆製薬産業に関するニュース

CanSino Claims Lead In COVID-19 Vaccine Race And Takes Swipe At Moderna's Ethics

Vaccines veteran calls Moderna ‘shabby’ for lack of transparency and shares sell-off, and flags CanSino’s own forthcoming Phase II results.

Topic Coronavirus Clinical Trials Vaccines

Medtech Insight: 世界の医療機器・医療技術の最新情報

Senate Bills Would Require More COVID-19 PPE, US Manufacturing Capacity, Use Of Analytical Imaging

Legislators at a 23 June Senate health panel hearing exploring prevention of future pandemics similar to COVID-19 discussed legislation they have recently introduced to resolve the current viral crisis.

Topic Coronavirus Legislation

Medtech Insight: 世界の医療機器・医療技術の最新情報

Diagnostics Industry In Spotlight As Germany Doubles Down To Prevent Second COVID-19 Wave

Germany’s authorities are back on guard against COVID-19 following renewed regional outbreaks. Diagnostics manufacturers will continue to play a strong part in bringing the pandemic substantially under control, a recent industry association virtual conference heard.

Topic Coronavirus policy-and-regulation

Generics Bulletin: ジェネリック＆バイオシミラーニュース

Glenmark Debuts Favipiravir For COVID-19 In India

Glenmark has received the go-ahead in India for and launched its low-priced favipiravir product for mild to moderate COVID-19 under an accelerated approval process.

Topic Coronavirus Drug Review

HBW Insight : コンシューマーヘルスケア産業のニュース

US COVID-19 Fraud: Licorice Promoted As Treatment, Unapproved Tests Offered OTC

FDA and FTC continue adding to total each has made during novel coronavirus pandemic. FTC's latest include peroxide gel and licorice as treatments; FDA’s emphasizes in warnings that three businesses' tests were not approved for OTC sales or for home use.

Topic Coronavirus Dietary Supplements

Pink Sheet: 世界の薬事規制と承認審査に関するニュース

Patient-Reported Data In COVID-Impacted Trials: US FDA Cautions Against Missing Data, Potential Bias

Considerations for switching from in-person to remote collection of patient- and observer-reported outcomes addressed in latest update to Q&A guidance, which also discusses Part 11 compliance requirements in the context of the pandemic and electronic collection of informed consent through MyStudies app.

Topic Coronavirus clinical-trials